NCT06401265

Brief Summary

Among urothelial cancers, upper urinary tract urothelial cancers, including renal pelvis and ureteral cancers have a higher incidence rate in Taiwan than Western countries. In particular, the proportion of female patients is similar to that of males. This situation is significantly different from that in foreign countries. The cause is currently uncertain.In the past, the arsenic contamination of groundwater made blackfoot disease become common and malignant in areas. Now, the number of kidney dialysis patients in Taiwan is increasing; and according to statistics, there is a significantly higher incidence of urothelial cancer among kidney dialysis patients. This may be caused by the use of traditional Chinese medicine or other unknown reasons.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 8, 2018

Completed
4.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 5, 2022

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

May 2, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 6, 2024

Completed
Last Updated

May 6, 2024

Status Verified

February 1, 2022

Enrollment Period

1 month

First QC Date

May 2, 2024

Last Update Submit

May 2, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • It is a retrospective and questionnaire-based study.

    Patients with urothelial carcinoma of the upper urinary tract from January 2008 to December 2019.

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with upper urinary tract urothelial carcinoma

You may qualify if:

  • Case study of upper urinary tract urothelial cancer surgery

You may not qualify if:

  • Cases of surgery for non-upper urinary tract urothelial cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tzu Chi hospital

Taipei, Taiwan

Location

MeSH Terms

Conditions

Uterine Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2024

First Posted

May 6, 2024

Study Start

January 1, 2018

Primary Completion

February 8, 2018

Study Completion

September 5, 2022

Last Updated

May 6, 2024

Record last verified: 2022-02

Locations